PROTAC | Institute for Neuroplasticity Research

Posts Tagged ‘PROTAC’

Can Proteins be Modified to Fight Diseases and Cancer?

Posted by Michael A. S. Guth on January 4th, 2024

Proteolysis Targeting Chimera

Posted in Regulatory Medical Writing

Tags: Disease-Causing Proteins, monoclonal antibodies (mAbs), NF-κB, PROTAC, Proteolysis Targeting Chimera, Proteolysis Targeting Chimerics, small molecule inhibitors (SMIs), transcription factors, Ubiquitin-Proteasome System (UPS)

Comments Off

Recent Posts
Tags
AHCC Calcifediol study CASIRIVIMAB Disease-Causing Proteins first cell GIP GLP-1 IMDEVIMAB Interferon Melatonin monoclonal antibodies (mAbs) NF-κB PROTAC Proteolysis Targeting Chimera Proteolysis Targeting Chimerics SHADE study small molecule inhibitors (SMIs) Tirzepatide transcription factors Ubiquitin-Proteasome System (UPS)
Calendar

December 2025

S M T W T F S

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30 31

« Nov
Links
- 1. Dr. Eugene Guth, my father
- 2. Roma Claire Guth, my mother

Powered by Medical Writing and Epidemiology